Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

[video]This Small Biotech Will Profit From the Hep C Drug Race
Motley Fool
Fri, 03/14/14 - 08:41 am
Tags:
biotech, Enanta Pharmaceuticals, hepatitis C, Gilead Sciences, AbbVie
Can Gilead Dominate The HIV Drug Market Again in 2014?
Motley Fool
Wed, 03/12/14 - 06:58 pm
Tags:
HIV, Gilead Sciences, Stribild, Truvada, Atripla
Medical groups question price of new hep C drug
Yahoo/AP
Tue, 03/11/14 - 03:00 pm
Tags:
Sovaldi, drug pricing, California, Gilead Sciences, hepatitis C
With Solvadi in the mix, the FDA's class of 2013 is set for chart-busting sales
Fierce Pharma
Tue, 03/11/14 - 12:00 pm
Tags:
Sovaldi, FDA, Gilead Sciences, Novo Nordisk, AbbVie, Biogen Idec
Catalysts That Could Push Top Biotech Stocks Even Higher
Wall St 24/7
Tue, 03/11/14 - 10:04 am
Tags:
biotech, Biogen Idec, Gilead Sciences, Illumina, United Therapeutics, Vertex Pharmaceuticals
Prices of new hepatitis C drugs are tough to swallow for insurers
LA Times, CA
Mon, 03/10/14 - 08:19 am
Tags:
insurance, hepatitis C, Sovaldi, Gilead Sciences, Olysio, JNJ, Janssen
Gilead's Sovaldi sales through the roof already, analyst predicts at least $8B this year
Fierce Pharma
Fri, 03/7/14 - 12:14 pm
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Costly hepatitis drug Sovaldi rattles industry
Washington Post, DC
Wed, 03/5/14 - 09:06 am
Tags:
Sovaldi, drug pricing, hepatitis C, Gilead Sciences
AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
Tags:
AbbVie, hepatitis C, ABT-450, ABT-267, ABT-333, Gilead Sciences, Bristol-Myers Squibb
3 Things to Watch at Gilead
Motley Fool
Tue, 02/25/14 - 07:24 am
Tags:
Gilead Sciences, Sovaldi, HIV, hepatitis C
Biotech: Too Big for Its Britches?
Barron's
Mon, 02/24/14 - 05:05 pm
Tags:
biotech, Celgene, Gilead Sciences, Biogen Idec, Amgen, Regeneron
Gilead: AbbVie No Match For Sovaldi
Barron's
Sat, 02/22/14 - 10:41 am
Tags:
Gilead Sciences, AbbVie, Sovaldi, hepatitis, hepatitis C
Gilead's Hepatitis C Pill Takes Off Like A Rocket
Forbes
Fri, 02/21/14 - 09:07 am
Tags:
Sovaldi, Gilead Sciences, hepatitis C
Biotech Stock Roundup: Regeneron's Eylea Impresses, Gilead Files for Next HCV Drug
Yahoo/Zacks.com
Wed, 02/19/14 - 09:26 am
Tags:
Regeneron, Eylea, Gilead Sciences, ledipasvir, Sovaldi, hepatitis C, Cangrelor, The Medicines Company
ViiV, Gilead sweep the pharma image competition--and Pfizer is close behind
Fierce Pharma
Mon, 02/17/14 - 07:47 pm
Tags:
Gilead Sciences, ViiV, Pfizer
The Zacks Analyst Blog Highlights: Gilead, Cytokinetics, Puma, Biogen and Spectrum Pharmaceuticals
Yahoo/Zacks.com
Thu, 02/13/14 - 09:18 am
Tags:
Gilead Sciences, Cytokinetics, Puma Biotechnology, Biogen Idec, Spectrum Pharmaceuticals
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wed, 02/12/14 - 09:50 am
Tags:
Actelion, Gilead Sciences, Opsumit, Letairis, PAH, pulmonary arterial hypertension
Gilead’s Milligan Says Hepatitis C Drug Attracts Payers
Bloomberg
Wed, 02/12/14 - 09:11 am
Tags:
Gilead Sciences, hepatitus C, Sovaldi, insurance
Gilead Sciences: Sovaldi Exclusion No Big Deal
Barron's
Mon, 02/10/14 - 05:27 pm
Tags:
Sovaldi, Gilead Sciences, hepatitis C
The Hep C Race Is Heating Up: AbbVie Vs. Gilead
Seeking Alpha
Mon, 02/10/14 - 08:35 am
Tags:
AbbVie, Gilead Sciences, hepatitis C, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.